{{Rsnum
|rsid=13028485
|Chromosome=2
|position=173640196
|Orientation=plus
|GMAF=0.1116
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.0 | 15.0 | 85.0
| HCB | 4.4 | 34.3 | 61.3
| JPT | 6.2 | 36.3 | 57.5
| YRI | 1.4 | 16.3 | 82.3
| ASW | 0.0 | 17.5 | 82.5
| CHB | 4.4 | 34.3 | 61.3
| CHD | 2.8 | 35.8 | 61.5
| GIH | 1.0 | 20.8 | 78.2
| LWK | 0.9 | 22.7 | 76.4
| MEX | 0.0 | 15.5 | 84.5
| MKK | 0.0 | 16.7 | 83.3
| TSI | 0.0 | 11.8 | 88.2
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23502783
  |Trait=Multiple myeloma (IgH translocation)
  |Title=The CCND1 c.870G>A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma.
  |RiskAllele=A
  |Pval=2E-6
  |OR=2.17
  |ORtxt=[1.57-2.99]
  }}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}